Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Randomized Controlled Clinical Trial of High-frequency nrTMS on the Contralateral Broca Mirror Area for Language Recovery in Patients With Non-fluent Aphasia After Glioma Surgery

NCT05788445 is registered in ClinicalTrials.gov with Beijing Neurosurgical Institute as lead sponsor.

NCT NCT05788445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05788445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Randomized Controlled Clinical Trial of High-frequency nrTMS on the Contralateral Broca Mirror Area for Language Recovery in Patients With Non-fluent Aphasia After Glioma Surgery
Lead sponsor
Beijing Neurosurgical Institute
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2023
Completion date
May 31, 2025
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, non-fluent aphasia